The term artificial intelligence was first coined in the 1950s. But until recently, the adoption of the technology was confined to fantastical Hollywood movie scripts, or it appeared in the musings of a select few software engineers and innovative CIO strategists. Today, artificial intelligence is a daily ... READ MORE >
artificial intelligence
5 things to know in life sciences: Week of April 24, 2023
This week we look at a World Health Organization meeting on mRNA, using artificial intelligence to streamline clinical trials, Food and Drug Administration approval of a new blood cancer treatment and an upcoming Johnson & Johnson spinout. Finally, we highlight the resumption of a phase 2 trial on an ... READ MORE >
Financial services update: Q4 banking, AI-powered funds, regulatory proposals
In the latest installment of our monthly financial services update, we take a look at banking results from the fourth quarter of 2022, artificial intelligence-powered funds, and two regulatory proposals. Q4 banking results The bank failures of early March have changed the landscape for financial ... READ MORE >
5 things to know in life sciences: Week of Jan. 23, 2023
This week we look at an emerging funding source within biotechs, the hottest topics during the recent JP Morgan Healthcare Conference, a revolutionary app to automate insulin dosing, the struggle for Medicare reimbursement of obesity drugs, and the Food and Drug Administration’s final guidance on ... READ MORE >
5 things to know in life sciences: Week of Nov. 28, 2022
This week we look at mRNA technology that could be used in a universal flu vaccine, the rise in digital therapies despite a lack of insurance coverage, and another drug breaking the record for most expensive in the world. We also look at a new Centers for Disease Control and Prevention program to monitor ... READ MORE >
5 things to know in life sciences: Week of Nov. 14, 2022
This week we look at a program focused on identifying biases from artificial intelligence-powered diagnostics, a study exploring the possibility of dissolvable stents and staples, and an AI-powered solution targeted at physicians and caregivers. Finally, we review a Food and Drug Administration ... READ MORE >
Government services companies are focusing on national defense, labor challenges
Government services executives continue to focus on hiring and retention, although the Russia-Ukraine war dominated discourse during the first quarter of 2022. Meanwhile, optimism around future spending, investment and opportunity stems from President Joe Biden’s fiscal year 2023 budget request and strong ... READ MORE >
Increased demand lifts defense technology companies amid inflation and supply chain issues
Executives in the defense technology ecosystem continue to experience rising costs and supply chain disruptions. However, growing international demand and technological innovation are driving optimism and investment for the future. The executives shared their perspectives recently in earnings calls ... READ MORE >
5 things to know in life sciences: Week of Feb. 28, 2022
This week we highlight clinical holds on cell and gene therapies, clinical trials and patient experience, artificial intelligence and identifying bone fractures, and more. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Cell and gene therapies ... READ MORE >
5 things to know in life sciences: Week of Feb. 21, 2022
This week we highlight a personalized blood testing company, an artificial intelligence-based software platform capable of detecting heart disease and a promising mRNA technology that can heal bone defects. In addition, we look at a novel company providing a kidney care solution as well as Nintendo and ... READ MORE >